ATR Axon

1.9k total citations · 1 hit paper
9 papers, 1.4k citations indexed

About

ATR Axon is a scholar working on Oncology, Epidemiology and Genetics. According to data from OpenAlex, ATR Axon has authored 9 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Epidemiology and 3 papers in Genetics. Recurrent topics in ATR Axon's work include Colorectal Cancer Screening and Detection (3 papers), Microscopic Colitis (3 papers) and Inflammatory Bowel Disease (3 papers). ATR Axon is often cited by papers focused on Colorectal Cancer Screening and Detection (3 papers), Microscopic Colitis (3 papers) and Inflammatory Bowel Disease (3 papers). ATR Axon collaborates with scholars based in United Kingdom, Japan and Australia. ATR Axon's co-authors include D M Chalmers, A.M. Snelling, Shigeo Yoshida, Takahiro Fujii, Anita Cairns, I V Weller, Christiane Neumann, BG Gazzard, G.A.J. Ayliffe and P.J.V. Hanson and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

ATR Axon

9 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

1999 805 citations A.M. Snelling, D M Chalmers et al. The Lancet profile →

Peers

Countries citing papers authored by ATR Axon

Since Specialization

Citations

This map shows the geographic impact of ATR Axon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ATR Axon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ATR Axon more than expected).

Fields of papers citing papers by ATR Axon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ATR Axon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ATR Axon. The network helps show where ATR Axon may publish in the future.

Co-authorship network of co-authors of ATR Axon

This figure shows the co-authorship network connecting the top 25 collaborators of ATR Axon. A scholar is included among the top collaborators of ATR Axon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with ATR Axon. ATR Axon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK 2000 ·The Lancet ·(unknown), Takahiro Fujii, Anita Cairns, (unknown), Shigeo Yoshida, D M Chalmers, ATR Axon	448
2	Recognising lesions on colonoscopy 2000 ·The Lancet ·(unknown), Takaaki Fujii, (unknown), (unknown), ATR Axon	1
3	Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial breakdown → 1999 ·The Lancet ·(unknown), A.M. Snelling, (unknown), D M Chalmers, ATR Axon	805
4	Escherichia coli for ulcerative colitis 1999 ·The Lancet ·(unknown), A.M. Snelling, (unknown), D M Chalmers, ATR Axon	2
5	Early gastric cancer: disease or pseudo-disease? 1998 ·The Lancet ·(unknown), ATR Axon	45
6	The influence of dyspepsia, Helicobacter pylori status and irritable bowel syndrome on quality of life in the community 1998 ·Gastroenterology ·Paul Moayyedi, David Braunholtz, (unknown), (unknown), S. B. Mason, ATR Axon	4
7	Perfect function after pouch surgery - what makes the difference? 1995 ·Gastroenterology ·(unknown), Wyn G. Lewis, (unknown), (unknown), (unknown), ATR Axon, D Johnston	3
8	Carcinogenesis in Ulcerative Colitis: Is Surveillance Worthwhile? 1990 ·SHILAP Revista de lepidopterología ·ATR Axon	5
9	CLEANING AND DISINFECTION OF EQUIPMENT FOR GASTROINTESTINAL FLEXIBLE ENDOSCOPY - INTERIM RECOMMENDATIONS OF A WORKING PARTY OF THE BRITISH-SOCIETY-OF-GASTROENTEROLOGY - REPLY 1989 ·UCL Discovery (University College London) ·I V Weller, (unknown), (unknown), BG Gazzard, ATR Axon, P.J.V. Hanson, G.A.J. Ayliffe, (unknown), Christiane Neumann	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact